Added to YB: 2025-09-10
Pitch date: 2025-07-25
ICU [bullish]
SeaStar Medical Holding Corporation
-57.29%
current return
Author Info
No bio for this author
Company Info
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.
Market Cap
$22.2M
Pitch Price
$0.75
Price Target
3.86 (+1102%)
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.39
EV/Sales
20.74
Sector
Health Care Equipment and Supplies
Category
growth
SeaStar Medical Holding Corporation - $ICU
ICU: Medtech co w/ FDA-approved QUELIMMUNE for pediatric AKI (77% survival vs 50% standard care). Adult AKI trial 50% enrolled, interim data late 3Q, PMA filing 2026. $4.5B adult AKI TAM vs $100M pediatric. ~$10M cash, $3M quarterly burn. 4-5x upside w/ 30%+ IRR potential if adult trial succeeds.
Read full article (7 min)